Orthopedic regenerative sports medicine: info@austinorthobio.com

Skip to main content

A Re-Look at the Value of Cell-Based (Formerly "Stem Cell") Therapy

 

Human bone marrow mesenchymal cell-based injection in subchondral lesions of knee osteoarthritis: a prospective randomized study versus contralateral arthroplasty at a mean fifteen year follow-up.

Philippe Hernigou  et. al.

6 April 2020

# SICOT   International Orthopaedics

Conclusions This study showed that subchondral bone marrow concentrate (BMC, as compared with knee replacement surgery, TKA) had a sufficient effect on pain to postpone or avoid the TKA in the other, affected knee joint of patients with bilateral [both knee] osteoarthritis.

Biologic Subchondral Injection

For over seven years, Kelly Cunningham MD, of Austin OrthoBiologics has been using mesenchymal cell-based treatment (BMC, from a patient’s own bone marrow) to successfully treat the pain and disability of mild to moderate knee arthritis.

Now, the cell-based therapy frontier is yielding good results of another exciting procedure that can be combined with BMC joint injection:

Subchondroplasty is the intraosseous (in-bone) injection of cell -based therapy, with or without a bone substitute, to augment the pain relief of BMC joint injection alone.

In layman‘s terms, your own harvested cell-based BMC can now be used not only in the joint, but in the adjacent stress-affected knee bone (end of femur/top of tibia-shin) to magnify the effect; lessening pain and improving function.

Based on the pioneering work of Dr. Philip Hernigou & others, years of European trials & treatments have revealed that the response of damaged bone to the growth factors and “paracrine” signals from these cell-based products can be dramatic. Now, the longer time period of follow-up of a previous paper reveals a statistically significant delay in "second-side" knee replacement surgery, presumably due to prolonged pain relief from the injections.

These are innovative applications of the pain-relieving effects of cell-based treatment. They pair well with office- or day surgery-based treatments of not only the knee, but shoulder, hip, elbow & ankle as well.

Dr. Cunningham was one of the first surgeons in Austin to offer subchondral cell-based injection as both an office and co-surgical treatment for his patients. Early results with respect to return to sport/activity can be remarkable; often far sooner than surgery or traditional treatments alone.

Other regenerative treatment options for orthopedic injury & arthritic joints include PRP "Platelet-Rich Plasma" and Lipo-aspirate (MFAT, fat cell-based therapy, to be discussed in an upcoming blog).

Orthopedic regenerative techniques continue to evolve, to the benefit of our patients!

Kelly Cunningham MD

Board-certified Orthopedic Surgeon

Regenerative Sports Medicine Specialist

           Austin Ortho Biologics          austinorthobio.com

 

 

Author
Dr. Kelly Cunningham Physician

You Might Also Enjoy...

Kelly Cunningham, MD Texas Top Doctor

For the third year in a row, Dr, Kelly Cunningham has been named a Texas Top Doctor for 2024. Combining traditional shoulder & knee orthopedic surgery/sports medicine with cutting-edge biologics/regenerative medicine.

BEAR Implant ACL Repair

BEAR (Bridge-Enhanced) ACL Repair is another tool (in addition to BMC "stem cell" repair) to address acute tears of the anterior cruciate ligament (ACL) of the knee.